Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · IEX Real-Time Price · USD
35.55
-0.16 (-0.45%)
At close: Jul 19, 2024, 4:00 PM
35.45
-0.10 (-0.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Protagonist Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PTGX stock have an average target of 40, with a low estimate of 37 and a high estimate of 45. The average target predicts an increase of 12.52% from the current stock price of 35.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 17, 2024.
Analyst Ratings
The average analyst rating for PTGX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $45 | Buy | Reiterates | $45 | +26.58% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +6.89% | Jun 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +6.89% | May 9, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $42 → $45 | Buy | Maintains | $42 → $45 | +26.58% | May 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +6.89% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
280.49M
from 60.00M
Increased by 367.48%
Revenue Next Year
137.70M
from 280.49M
Decreased by -50.91%
EPS This Year
1.42
from -1.39
EPS Next Year
-1.64
from 1.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 315.0M | 346.5M | 272.2M | 272.7M | 513.1M |
| Avg | 280.5M | 137.7M | 172.9M | 191.4M | 365.6M |
| Low | 249.9M | n/a | 77.0M | 103.8M | 158.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 425.0% | 23.5% | 97.7% | 57.7% | 168.1% |
| Avg | 367.5% | -50.9% | 25.6% | 10.7% | 91.0% |
| Low | 316.4% | - | -44.1% | -40.0% | -17.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.43 | 1.83 | -1.43 | -0.30 | 2.99 |
| Avg | 1.42 | -1.64 | -2.61 | -0.79 | 1.00 |
| Low | 0.85 | -3.35 | -3.80 | -1.23 | -0.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 29.1% | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.